WHITE PETROLATUM

N/A

Manufactured by Aldermed Inc.

2,618 FDA adverse event reports analyzed

Last updated: 2026-04-15

About WHITE PETROLATUM

WHITE PETROLATUM is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Aldermed Inc.. The most commonly reported adverse reactions for WHITE PETROLATUM include PYREXIA, RASH, DIARRHOEA, NAUSEA, PNEUMONIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for WHITE PETROLATUM.

Top Adverse Reactions

PYREXIA80 reports
RASH77 reports
DIARRHOEA73 reports
NAUSEA72 reports
PNEUMONIA66 reports
DRUG INEFFECTIVE54 reports
VOMITING52 reports
DYSPNOEA51 reports
OFF LABEL USE51 reports
PRURITUS49 reports
ANAEMIA47 reports
DIZZINESS42 reports
FEBRILE NEUTROPENIA42 reports
DEATH41 reports
DECREASED APPETITE41 reports
HEADACHE41 reports
CELLULITIS40 reports
FALL38 reports
FATIGUE38 reports
PAIN38 reports
SEPSIS38 reports
CONSTIPATION37 reports
MALAISE37 reports
URINARY TRACT INFECTION37 reports
ERYTHEMA36 reports
DEHYDRATION35 reports
PLATELET COUNT DECREASED32 reports
CONDITION AGGRAVATED31 reports
INSOMNIA31 reports
ABDOMINAL PAIN30 reports
CARDIAC FAILURE29 reports
PLEURAL EFFUSION28 reports
ARTHRALGIA26 reports
ASTHENIA26 reports
BLOOD BILIRUBIN INCREASED26 reports
COUGH25 reports
WHITE BLOOD CELL COUNT DECREASED25 reports
ACUTE KIDNEY INJURY23 reports
DELIRIUM23 reports
WEIGHT DECREASED23 reports
CHEST PAIN22 reports
DERMATITIS ATOPIC22 reports
DRY SKIN22 reports
HEPATIC FUNCTION ABNORMAL22 reports
INTERSTITIAL LUNG DISEASE22 reports
SKIN EXFOLIATION22 reports
HAEMOGLOBIN DECREASED20 reports
HYPERTENSION20 reports
NEUROPATHY PERIPHERAL20 reports
NEUTROPHIL COUNT DECREASED20 reports
PNEUMONIA ASPIRATION20 reports
RESPIRATORY FAILURE20 reports
NASOPHARYNGITIS19 reports
OEDEMA PERIPHERAL19 reports
PAIN IN EXTREMITY19 reports
RENAL IMPAIRMENT19 reports
SEPTIC SHOCK19 reports
BACK PAIN18 reports
BRONCHITIS18 reports
ALOPECIA17 reports
DYSPEPSIA17 reports
HYPOAESTHESIA17 reports
HYPOKALAEMIA17 reports
HYPOTENSION17 reports
NEUTROPENIA17 reports
RENAL FAILURE17 reports
STEVENS JOHNSON SYNDROME17 reports
STOMATITIS17 reports
URINARY RETENTION17 reports
C REACTIVE PROTEIN INCREASED16 reports
DEPRESSION16 reports
HYPONATRAEMIA16 reports
MUSCULAR WEAKNESS16 reports
SKIN INFECTION16 reports
DISSEMINATED INTRAVASCULAR COAGULATION15 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION15 reports
LIP SWELLING15 reports
PALMAR PLANTAR ERYTHRODYSAESTHESIA SYNDROME15 reports
COVID 1914 reports
ECZEMA14 reports
FEELING ABNORMAL14 reports
HYPERGLYCAEMIA14 reports
PRODUCT USE ISSUE14 reports
SCHIZOPHRENIA14 reports
URTICARIA14 reports
VISION BLURRED14 reports
ANXIETY13 reports
ASPARTATE AMINOTRANSFERASE INCREASED13 reports
ASTHMA13 reports
BLISTER13 reports
COELIAC DISEASE13 reports
DEPENDENCE13 reports
DRUG ERUPTION13 reports
HYPERSENSITIVITY13 reports
HYPOTHYROIDISM13 reports
INFUSION RELATED REACTION13 reports
IRON DEFICIENCY ANAEMIA13 reports
PRODUCT COMPLAINT13 reports
PRODUCT DOSE OMISSION ISSUE13 reports
PRODUCT USE IN UNAPPROVED INDICATION13 reports

Report Outcomes

Out of 1,338 classified reports for WHITE PETROLATUM:

Serious 81.7%Non-Serious 18.3%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female634 (51.6%)
Male593 (48.3%)
Unknown1 (0.1%)

Reports by Age

Age 5332 reports
Age 7432 reports
Age 6631 reports
Age 5429 reports
Age 7327 reports
Age 6525 reports
Age 6725 reports
Age 7524 reports
Age 5623 reports
Age 7223 reports
Age 7823 reports
Age 6021 reports
Age 7121 reports
Age 7020 reports
Age 5019 reports
Age 5719 reports
Age 5819 reports
Age 6319 reports
Age 7619 reports
Age 4118 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with WHITE PETROLATUM?

This profile reflects 2,618 FDA FAERS reports that mention WHITE PETROLATUM. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for WHITE PETROLATUM?

Frequently reported terms in FAERS include PYREXIA, RASH, DIARRHOEA, NAUSEA, PNEUMONIA, DRUG INEFFECTIVE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures WHITE PETROLATUM?

Labeling and FAERS entries often list Aldermed Inc. in connection with WHITE PETROLATUM. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.